Clinical Outcomes of Children With COVID-19 by SARS-CoV-2 Strain: A Cohort Study
- PMID: 37665790
- DOI: 10.1097/PEC.0000000000003034
Clinical Outcomes of Children With COVID-19 by SARS-CoV-2 Strain: A Cohort Study
Abstract
Objective: We sought to investigate the disease outcomes and predictors of severe outcomes among children infected with the Delta variant of SARS-CoV-2 compared with pre-Delta strains.
Methods: Single-center retrospective cohort study in an emergency department located within an urban academic children's hospital. Patients included children (0-18 years) who tested positive for SARS-CoV-2. Main outcomes measured include need for hospital admission or COVID-directed therapies.
Results: There was a trend toward decreased hospital admission and no significant difference in the severity of outcomes in the Delta cohort relative to the pre-Delta cohort. The Delta cohort had lower odds of hospital admission (odds ratio [OR], 0.79; 95% confidence interval [CI], 0.51-1.23), but the result was not statistically significant. Logistic regression analyses showed that overall, age 1 to 4 years (OR, 2.35; 95% CI, 1.23-4.57) and public insurance (OR, 1.80, 95% CI, 1.08-3.01) were predictors of hospital admission. Within the Delta cohort, the presence of any comorbidity increased the odds of admission (OR, 2.52; 95% CI, 1.09-6.04). Black children had lower odds of admission than white children (overall OR, 0.53; 95% CI, 0.31-0.90; pre-Delta OR, 0.50; 95% CI, 0.26-0.95).
Conclusions: The severity of measured disease outcomes was similar in pediatric patients when comparing children infected with the pre-Delta and Delta variants of SARS-CoV-2, even among children with comorbidities once adjusting for acuity.Ongoing research is essential to determine disease severity and risk for children with comorbidities because SARS-CoV-2 continues to mutate, including with Omicron subvariants.
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Conflict of interest statement
Disclosure: The authors declare no conflict of interest.
References
-
- Stilwell PA, Munro APS, Basatemur E, et al. Bibliography of published COVID-19 in children literature. Arch Dis Child . 2022;107:168–172.
-
- CDC. Delta variant: what we know about the science. Available from: https://www.cdc.gov/coronavirus/2019-ncov/variants/delta-variant.html . Accessed May 22, 2022.
-
- Parcha V, Booker KS, Kalra R, et al. A retrospective cohort study of 12,306 pediatric COVID-19 patients in the United States. Sci Rep . 2021;11:10231.
-
- Patel NA. Pediatric COVID-19: systematic review of the literature. Am J Otolaryngol . 2020;41:102573.
-
- Shekerdemian LS, Mahmood NR, Wolfe KK, et al. Characteristics and outcomes of children with coronavirus disease 2019 (COVID-19) infection admitted to US and Canadian pediatric intensive care units. JAMA Pediatr . 2020;174:868–873.
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous